Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2951

1.

A Community-Based Mindfulness Intervention Among Latino Adolescents and Their Parents: A Qualitative Feasibility and Acceptability Study.

Tobin J, Hardy J, Calanche ML, Gonzalez KD, Baezconde-Garbanati L, Contreras R, Bluthenthal RN.

J Immigr Minor Health. 2020 Feb 20. doi: 10.1007/s10903-020-00985-9. [Epub ahead of print]

PMID:
32078725
2.

Conception and viable twin pregnancy in a patient with metastatic melanoma while treated with CTLA-4 and PD-1 checkpoint inhibition.

Bucheit AD, Hardy JT, Szender JB, Glitza Oliva IC.

Melanoma Res. 2020 Feb 17. doi: 10.1097/CMR.0000000000000657. [Epub ahead of print]

PMID:
32073510
3.

Author Correction: Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.

Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, Sealock J, Karlsson IK, Hägg S, Athanasiu L, Voyle N, Proitsi P, Witoelar A, Stringer S, Aarsland D, Almdahl IS, Andersen F, Bergh S, Bettella F, Bjornsson S, Brækhus A, Bråthen G, de Leeuw C, Desikan RS, Djurovic S, Dumitrescu L, Fladby T, Hohman TJ, Jonsson PV, Kiddle SJ, Rongve A, Saltvedt I, Sando SB, Selbæk G, Shoai M, Skene NG, Snaedal J, Stordal E, Ulstein ID, Wang Y, White LR, Hardy J, Hjerling-Leffler J, Sullivan PF, van der Flier WM, Dobson R, Davis LK, Stefansson H, Stefansson K, Pedersen NL, Ripke S, Andreassen OA, Posthuma D.

Nat Genet. 2020 Feb 6. doi: 10.1038/s41588-019-0573-x. [Epub ahead of print]

PMID:
32029921
4.

Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma - findings from the PRACTICAL study, a randomised clinical trial.

Baggott C, Reddel HK, Hardy J, Sparks J, Holliday M, Corin A, Montgomery B, Reid J, Sheahan D, Hancox RJ, Weatherall M, Beasley R, Fingleton J; PRACTICAL study team.

Eur Respir J. 2020 Feb 6. pii: 1902073. doi: 10.1183/13993003.02073-2019. [Epub ahead of print]

PMID:
32029450
5.

Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study.

Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, Chen Y, Su Y, Myers AJ, Hardy J, Paul Vonsattel J, Younkin SG, Bennett DA, De Jager PL, Larson EB, Crane PK, Keene CD, Kamboh MI, Kofler JK, Duque L, Gilbert JR, Gwirtsman HE, Buxbaum JD, Dickson DW, Frosch MP, Ghetti BF, Lunetta KL, Wang LS, Hyman BT, Kukull WA, Foroud T, Haines JL, Mayeux RP, Pericak-Vance MA, Schneider JA, Trojanowski JQ, Farrer LA, Schellenberg GD, Beecham GW, Montine TJ, Jun GR; Alzheimer’s Disease Genetics Consortium.

Nat Commun. 2020 Feb 3;11(1):667. doi: 10.1038/s41467-019-14279-8.

6.

Prediction of Drug Loading in the Gelatin Matrix Using Computational Methods.

Hathout RM, Metwally AA, Woodman TJ, Hardy JG.

ACS Omega. 2020 Jan 13;5(3):1549-1556. doi: 10.1021/acsomega.9b03487. eCollection 2020 Jan 28.

7.

Novel monoclonal antibodies against Australian strains of negeviruses and insights into virus structure, replication and host -restriction.

Colmant AMG, O'Brien CA, Newton ND, Watterson D, Hardy J, Coulibaly F, Bielefeldt-Ohmann H, Warrilow D, Huang B, Paramitha D, Harrison JJ, Hall RA, Hobson-Peters J.

J Gen Virol. 2020 Jan 31. doi: 10.1099/jgv.0.001388. [Epub ahead of print]

PMID:
32003709
8.

Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies.

Orme T, Hernandez D, Ross OA, Kun-Rodrigues C, Darwent L, Shepherd CE, Parkkinen L, Ansorge O, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Trojanowski JQ, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday G, Stone DJ, Dickson DW, Hardy J, Singleton A, Guerreiro R, Bras J.

Acta Neuropathol Commun. 2020 Jan 29;8(1):5. doi: 10.1186/s40478-020-0879-z.

9.

Optimizing Nanohydroxyapatite Nanocomposites for Bone Tissue Engineering.

Lowe B, Hardy JG, Walsh LJ.

ACS Omega. 2019 Dec 18;5(1):1-9. doi: 10.1021/acsomega.9b02917. eCollection 2020 Jan 14. Review.

10.

Overcoming barriers to evidence-based patient blood management: a restricted review.

Delaforce A, Duff J, Munday J, Hardy J.

Implement Sci. 2020 Jan 17;15(1):6. doi: 10.1186/s13012-020-0965-4. Review.

11.

Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates.

Ling H, Gelpi E, Davey K, Jaunmuktane Z, Mok KY, Jabbari E, Simone R, R'Bibo L, Brandner S, Ellis MJ, Attems J, Mann D, Halliday GM, Al-Sarraj S, Hedreen J, Ironside JW, Kovacs GG, Kovari E, Love S, Vonsattel JPG, Allinson KSJ, Hansen D, Bradshaw T, Setó-Salvia N, Wray S, de Silva R, Morris HR, Warner TT, Hardy J, Holton JL, Revesz T.

Acta Neuropathol. 2020 Jan 16. doi: 10.1007/s00401-019-02119-4. [Epub ahead of print]

PMID:
31950334
12.

Traumatic ectopic dislocation of testis: an easily overlooked occurrence of blunt injury in polytrauma patients.

Lenfant M, Escoffier A, Chevallier O, Comby PO, Danan L, Hardy J, Loffroy R.

Quant Imaging Med Surg. 2019 Dec;9(12):2008-2011. doi: 10.21037/qims.2019.11.11. No abstract available.

13.

A fluorescence-activatable reporter of flavivirus NS2B-NS3 protease activity enables live imaging of infection in single cells and viral plaques.

Arias-Arias JL, MacPherson DJ, Hill ME, Hardy JA, Mora-Rodríguez R.

J Biol Chem. 2020 Feb 21;295(8):2212-2226. doi: 10.1074/jbc.RA119.011319. Epub 2020 Jan 9.

PMID:
31919100
14.

A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC-derived microglia.

Piers TM, Cosker K, Mallach A, Johnson GT, Guerreiro R, Hardy J, Pocock JM.

FASEB J. 2020 Feb;34(2):2436-2450. doi: 10.1096/fj.201902447R. Epub 2019 Dec 23.

15.

Failures in Protein Clearance Partly Underlie Late Onset Neurodegenerative Diseases and Link Pathology to Genetic Risk.

Hardy J.

Front Neurosci. 2019 Dec 5;13:1304. doi: 10.3389/fnins.2019.01304. eCollection 2019.

16.

Prevalence of QTc Prolongation in Patients With Advanced Cancer Receiving Palliative Care-A Cause for Concern?

Hardy JR, Bundock D, Cross J, Gibbons K, Pinkerton R, Kindl K, Good P, Philip J.

J Pain Symptom Manage. 2019 Dec 19. pii: S0885-3924(19)31061-9. doi: 10.1016/j.jpainsymman.2019.12.356. [Epub ahead of print]

PMID:
31866486
17.
18.

An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care.

Good PD, Greer RM, Huggett GE, Hardy JR.

J Palliat Med. 2019 Dec 3. doi: 10.1089/jpm.2019.0540. [Epub ahead of print]

PMID:
31800354
19.

Biocompatibility Investigation of Hybrid Organometallic Polymers for Sub-Micron 3D Printing via Laser Two-Photon Polymerisation.

Balčiūnas E, Dreižė N, Grubliauskaitė M, Urnikytė S, Šimoliūnas E, Bukelskienė V, Valius M, Baldock SJ, Hardy JG, Baltriukienė D.

Materials (Basel). 2019 Nov 27;12(23). pii: E3932. doi: 10.3390/ma12233932.

20.

An AARS variant as the likely cause of Swedish type hereditary diffuse leukoencephalopathy with spheroids.

Sundal C, Carmona S, Yhr M, Almström O, Ljungberg M, Hardy J, Hedberg-Oldfors C, Fred Å, Brás J, Oldfors A, Andersen O, Guerreiro R.

Acta Neuropathol Commun. 2019 Nov 27;7(1):188. doi: 10.1186/s40478-019-0843-y.

21.

Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.

Blauwendraat C, Reed X, Krohn L, Heilbron K, Bandres-Ciga S, Tan M, Gibbs JR, Hernandez DG, Kumaran R, Langston R, Bonet-Ponce L, Alcalay RN, Hassin-Baer S, Greenbaum L, Iwaki H, Leonard HL, Grenn FP, Ruskey JA, Sabir M, Ahmed S, Makarious MB, Pihlstrøm L, Toft M, van Hilten JJ, Marinus J, Schulte C, Brockmann K, Sharma M, Siitonen A, Majamaa K, Eerola-Rautio J, Tienari PJ; 23andMe Research Team, Pantelyat A, Hillis AE, Dawson TM, Rosenthal LS, Albert MS, Resnick SM, Ferrucci L, Morris CM, Pletnikova O, Troncoso J, Grosset D, Lesage S, Corvol JC, Brice A, Noyce AJ, Masliah E, Wood N, Hardy J, Shulman LM, Jankovic J, Shulman JM, Heutink P, Gasser T, Cannon P, Scholz SW, Morris H, Cookson MR, Nalls MA, Gan-Or Z, Singleton AB.

Brain. 2020 Jan 1;143(1):234-248. doi: 10.1093/brain/awz350.

22.

In Situ Crosslinking Bionanocomposite Hydrogels with Potential for Wound Healing Applications.

Leone F, Firlak M, Challen K, Bonnefin W, Onida B, Wright KL, Hardy JG.

J Funct Biomater. 2019 Nov 14;10(4). pii: E50. doi: 10.3390/jfb10040050.

23.

Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.

Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA, Noyce AJ, Xue A, Bras J, Young E, von Coelln R, Simón-Sánchez J, Schulte C, Sharma M, Krohn L, Pihlstrøm L, Siitonen A, Iwaki H, Leonard H, Faghri F, Gibbs JR, Hernandez DG, Scholz SW, Botia JA, Martinez M, Corvol JC, Lesage S, Jankovic J, Shulman LM, Sutherland M, Tienari P, Majamaa K, Toft M, Andreassen OA, Bangale T, Brice A, Yang J, Gan-Or Z, Gasser T, Heutink P, Shulman JM, Wood NW, Hinds DA, Hardy JA, Morris HR, Gratten J, Visscher PM, Graham RR, Singleton AB; 23andMe Research Team; System Genomics of Parkinson's Disease Consortium; International Parkinson's Disease Genomics Consortium.

Lancet Neurol. 2019 Dec;18(12):1091-1102. doi: 10.1016/S1474-4422(19)30320-5.

PMID:
31701892
24.

Do heterozygous mutations of Niemann-Pick type C predispose to late-onset neurodegeneration: a review of the literature.

Schneider SA, Tahirovic S, Hardy J, Strupp M, Bremova-Ertl T.

J Neurol. 2019 Nov 7. doi: 10.1007/s00415-019-09621-5. [Epub ahead of print] Review.

PMID:
31701332
25.

The Parkinson's Disease Mendelian Randomization Research Portal.

Noyce AJ, Bandres-Ciga S, Kim J, Heilbron K, Kia D, Hemani G, Xue A, Lawlor DA, Smith GD, Duran R, Gan-Or Z, Blauwendraat C, Gibbs JR; 23andMe Research Team5, International Parkinson's Disease Genomics Consortium (IPDGC), Hinds DA, Yang J, Visscher P, Cuzick J, Morris H, Hardy J, Wood NW, Nalls MA, Singleton AB.

Mov Disord. 2019 Dec;34(12):1864-1872. doi: 10.1002/mds.27873. Epub 2019 Oct 28.

26.

Severe obesity is associated with liver disease severity in pediatric non-alcoholic fatty liver disease.

Seth A, Orkin S, Yodoshi T, Liu C, Fei L, Hardy J, Trout AT, Arce Clachar AC, Bramlage K, Xanthakos S, Mouzaki M.

Pediatr Obes. 2020 Feb;15(2):e12581. doi: 10.1111/ijpo.12581. Epub 2019 Oct 27.

PMID:
31657145
27.

Low-molecular-mass iron complexes in blood plasma of iron-deficient pigs do not originate directly from nutrient iron.

Dziuba N, Hardy J, Lindahl PA.

Metallomics. 2019 Nov 1;11(11):1900-1911. doi: 10.1039/c9mt00152b. Epub 2019 Oct 11.

PMID:
31603444
28.

Informing disease modelling with brain-relevant functional genomic annotations.

Reynolds RH, Hardy J, Ryten M, Gagliano Taliun SA.

Brain. 2019 Dec 1;142(12):3694-3712. doi: 10.1093/brain/awz295.

29.

Histone deposition promotes recombination-dependent replication at arrested forks.

Hardy J, Dai D, Ait Saada A, Teixeira-Silva A, Dupoiron L, Mojallali F, Fréon K, Ochsenbein F, Hartmann B, Lambert S.

PLoS Genet. 2019 Oct 4;15(10):e1008441. doi: 10.1371/journal.pgen.1008441. eCollection 2019 Oct.

30.

Uptake and Release of Species from Carbohydrate Containing Organogels and Hydrogels.

Pan A, Roy SG, Haldar U, Mahapatra RD, Harper GR, Low WL, De P, Hardy JG.

Gels. 2019 Sep 30;5(4). pii: E43. doi: 10.3390/gels5040043.

31.

Single genome sequencing of near full-length HIV-1 RNA using a limiting dilution approach.

Hebberecht L, Vancoillie L, Schauvliege M, Staelens D, Demecheleer E, Hardy J, Mortier V, Verhofstede C.

J Virol Methods. 2019 Dec;274:113737. doi: 10.1016/j.jviromet.2019.113737. Epub 2019 Sep 25.

32.

The flagellotropic bacteriophage YSD1 targets Salmonella Typhi with a Chi-like protein tail fibre.

Dunstan RA, Pickard D, Dougan S, Goulding D, Cormie C, Hardy J, Li F, Grinter R, Harcourt K, Yu L, Song J, Schreiber F, Choudhary J, Clare S, Coulibaly F, Strugnell RA, Dougan G, Lithgow T.

Mol Microbiol. 2019 Dec;112(6):1831-1846. doi: 10.1111/mmi.14396. Epub 2019 Oct 9.

PMID:
31556164
33.

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease.

Sjödin S, Brinkmalm G, Öhrfelt A, Parnetti L, Paciotti S, Hansson O, Hardy J, Blennow K, Zetterberg H, Brinkmalm A.

Alzheimers Res Ther. 2019 Sep 14;11(1):82. doi: 10.1186/s13195-019-0533-9.

34.

Progress in the genetic analysis of Parkinson's disease.

Singleton A, Hardy J.

Hum Mol Genet. 2019 Nov 21;28(R2):R215-R218. doi: 10.1093/hmg/ddz183.

PMID:
31518392
35.

Methotrimeprazine versus haloperidol in palliative care patients with cancer-related nausea: a randomised, double-blind controlled trial.

Hardy JR, Skerman H, Philip J, Good P, Currow DC, Mitchell G, Yates P.

BMJ Open. 2019 Sep 12;9(9):e029942. doi: 10.1136/bmjopen-2019-029942.

36.

Effect of CFIm68 knockdown on RNA polymerase II transcription.

Tellier M, Hardy JG, Norbury CJ, Murphy S.

BMC Res Notes. 2019 Sep 2;12(1):554. doi: 10.1186/s13104-019-4582-8.

37.

Microvesicle-Mediated Delivery of Minicircle DNA Results in Effective Gene-Directed Enzyme Prodrug Cancer Therapy.

Kanada M, Kim BD, Hardy JW, Ronald JA, Bachmann MH, Bernard MP, Perez GI, Zarea AA, Ge TJ, Withrow A, Ibrahim SA, Toomajian V, Gambhir SS, Paulmurugan R, Contag CH.

Mol Cancer Ther. 2019 Dec;18(12):2331-2342. doi: 10.1158/1535-7163.MCT-19-0299. Epub 2019 Aug 26.

PMID:
31451563
38.

Reply to "Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management".

Startin CM, Hamburg S, Hithersay R, Al-Janabi T, Mok KY, Hardy J, Strydom A.

Alzheimers Dement. 2019 Sep;15(9):1238-1239. doi: 10.1016/j.jalz.2019.05.003. Epub 2019 Aug 23. No abstract available.

PMID:
31451423
39.

Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.

Hardy J, Baggott C, Fingleton J, Reddel HK, Hancox RJ, Harwood M, Corin A, Sparks J, Hall D, Sabbagh D, Mane S, Vohlidkova A, Martindale J, Williams M, Shirtcliffe P, Holliday M, Weatherall M, Beasley R; PRACTICAL study team.

Lancet. 2019 Sep 14;394(10202):919-928. doi: 10.1016/S0140-6736(19)31948-8. Epub 2019 Aug 23.

PMID:
31451207
40.

Endorsement and Constructive Criticism of an Innovative Online Reflexive Self-Talk Intervention.

Latinjak AT, Hernando-Gimeno C, Lorido-Méndez L, Hardy J.

Front Psychol. 2019 Aug 6;10:1819. doi: 10.3389/fpsyg.2019.01819. eCollection 2019.

41.

Culture-independent and dependent evaluation of the equine paranasal sinus microbiota in health and disease.

Beste KJ, Lawhon SD, Chamoun-Emanuelli AM, Duff AH, Coleman MC, Griffin CE, Hardy J, Whitfield-Cargile CM.

Equine Vet J. 2019 Aug 22. doi: 10.1111/evj.13168. [Epub ahead of print]

PMID:
31437314
42.

A Nanopore Approach for Analysis of Caspase-7 Activity in Cell Lysates.

Pham B, Eron SJ, Hill ME, Li X, Fahie MA, Hardy JA, Chen M.

Biophys J. 2019 Sep 3;117(5):844-855. doi: 10.1016/j.bpj.2019.07.045. Epub 2019 Aug 2.

PMID:
31427065
43.

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.

Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, Badarinarayan N, Jakobsdottir J, Hamilton-Nelson KL, Moreno-Grau S, Olaso R, Raybould R, Chen Y, Kuzma AB, Hiltunen M, Morgan T, Ahmad S, Vardarajan BN, Epelbaum J, Hoffmann P, Boada M, Beecham GW, Garnier JG, Harold D, Fitzpatrick AL, Valladares O, Moutet ML, Gerrish A, Smith AV, Qu L, Bacq D, Denning N, Jian X, Zhao Y, Del Zompo M, Fox NC, Choi SH, Mateo I, Hughes JT, Adams HH, Malamon J, Sanchez-Garcia F, Patel Y, Brody JA, Dombroski BA, Naranjo MCD, Daniilidou M, Eiriksdottir G, Mukherjee S, Wallon D, Uphill J, Aspelund T, Cantwell LB, Garzia F, Galimberti D, Hofer E, Butkiewicz M, Fin B, Scarpini E, Sarnowski C, Bush WS, Meslage S, Kornhuber J, White CC, Song Y, Barber RC, Engelborghs S, Sordon S, Voijnovic D, Adams PM, Vandenberghe R, Mayhaus M, Cupples LA, Albert MS, De Deyn PP, Gu W, Himali JJ, Beekly D, Squassina A, Hartmann AM, Orellana A, Blacker D, Rodriguez-Rodriguez E, Lovestone S, Garcia ME, Doody RS, Munoz-Fernadez C, Sussams R, Lin H, Fairchild TJ, Benito YA, Holmes C, Karamujić-Čomić H, Frosch MP, Thonberg H, Maier W, Roshchupkin G, Ghetti B, Giedraitis V, Kawalia A, Li S, Huebinger RM, Kilander L, Moebus S, Hernández I, Kamboh MI, Brundin R, Turton J, Yang Q, Katz MJ, Concari L, Lord J, Beiser AS, Keene CD, Helisalmi S, Kloszewska I, Kukull WA, Koivisto AM, Lynch A, Tarraga L, Larson EB, Haapasalo A, Lawlor B, Mosley TH, Lipton RB, Solfrizzi V, Gill M, Longstreth WT Jr, Montine TJ, Frisardi V, Diez-Fairen M, Rivadeneira F, Petersen RC, Deramecourt V, Alvarez I, Salani F, Ciaramella A, Boerwinkle E, Reiman EM, Fievet N, Rotter JI, Reisch JS, Hanon O, Cupidi C, Uitterlinden AGA, Royall DR, Dufouil C, Maletta RG, de Rojas I, Sano M, Brice A, Cecchetti R, George-Hyslop PS, Ritchie K, Tsolaki M, Tsuang DW, Dubois B, Craig D, Wu CK, Soininen H, Avramidou D, Albin RL, Fratiglioni L, Germanou A, Apostolova LG, Keller L, Koutroumani M, Arnold SE, Panza F, Gkatzima O, Asthana S, Hannequin D, Whitehead P, Atwood CS, Caffarra P, Hampel H, Quintela I, Carracedo Á, Lannfelt L, Rubinsztein DC, Barnes LL, Pasquier F, Frölich L, Barral S, McGuinness B, Beach TG, Johnston JA, Becker JT, Passmore P, Bigio EH, Schott JM, Bird TD, Warren JD, Boeve BF, Lupton MK, Bowen JD, Proitsi P, Boxer A, Powell JF, Burke JR, Kauwe JSK, Burns JM, Mancuso M, Buxbaum JD, Bonuccelli U, Cairns NJ, McQuillin A, Cao C, Livingston G, Carlson CS, Bass NJ, Carlsson CM, Hardy J, Carney RM, Bras J, Carrasquillo MM, Guerreiro R, Allen M, Chui HC, Fisher E, Masullo C, Crocco EA, DeCarli C, Bisceglio G, Dick M, Ma L, Duara R, Graff-Radford NR, Evans DA, Hodges A, Faber KM, Scherer M, Fallon KB, Riemenschneider M, Fardo DW, Heun R, Farlow MR, Kölsch H, Ferris S, Leber M, Foroud TM, Heuser I, Galasko DR, Giegling I, Gearing M, Hüll M, Geschwind DH, Gilbert JR, Morris J, Green RC, Mayo K, Growdon JH, Feulner T, Hamilton RL, Harrell LE, Drichel D, Honig LS, Cushion TD, Huentelman MJ, Hollingworth P, Hulette CM, Hyman BT, Marshall R, Jarvik GP, Meggy A, Abner E, Menzies GE, Jin LW, Leonenko G, Real LM, Jun GR, Baldwin CT, Grozeva D, Karydas A, Russo G, Kaye JA, Kim R, Jessen F, Kowall NW, Vellas B, Kramer JH, Vardy E, LaFerla FM, Jöckel KH, Lah JJ, Dichgans M, Leverenz JB, Mann D, Levey AI, Pickering-Brown S, Lieberman AP, Klopp N, Lunetta KL, Wichmann HE, Lyketsos CG, Morgan K, Marson DC, Brown K, Martiniuk F, Medway C, Mash DC, Nöthen MM, Masliah E, Hooper NM, McCormick WC, Daniele A, McCurry SM, Bayer A, McDavid AN, Gallacher J, McKee AC, van den Bussche H, Mesulam M, Brayne C, Miller BL, Riedel-Heller S, Miller CA, Miller JW, Al-Chalabi A, Morris JC, Shaw CE, Myers AJ, Wiltfang J, O'Bryant S, Olichney JM, Alvarez V, Parisi JE, Singleton AB, Paulson HL, Collinge J, Perry WR, Mead S, Peskind E, Cribbs DH, Rossor M, Pierce A, Ryan NS, Poon WW, Nacmias B, Potter H, Sorbi S, Quinn JF, Sacchinelli E, Raj A, Spalletta G, Raskind M, Caltagirone C, Bossù P, Orfei MD, Reisberg B, Clarke R, Reitz C, Smith AD, Ringman JM, Warden D, Roberson ED, Wilcock G, Rogaeva E, Bruni AC, Rosen HJ, Gallo M, Rosenberg RN, Ben-Shlomo Y, Sager MA, Mecocci P, Saykin AJ, Pastor P, Cuccaro ML, Vance JM, Schneider JA, Schneider LS, Slifer S, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Swerdlow RH, Tang M, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Van Eldik LJ, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Wilhelmsen KC, Williamson J, Wingo TS, Woltjer RL, Wright CB, Yu CE, Yu L, Saba Y; Alzheimer Disease Genetics Consortium (ADGC); European Alzheimer’s Disease Initiative (EADI); Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE); Genetic and Environmental Risk in AD/Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease Consortium (GERAD/PERADES), Pilotto A, Bullido MJ, Peters O, Crane PK, Bennett D, Bosco P, Coto E, Boccardi V, De Jager PL, Lleo A, Warner N, Lopez OL, Ingelsson M, Deloukas P, Cruchaga C, Graff C, Gwilliam R, Fornage M, Goate AM, Sanchez-Juan P, Kehoe PG, Amin N, Ertekin-Taner N, Berr C, Debette S, Love S, Launer LJ, Younkin SG, Dartigues JF, Corcoran C, Ikram MA, Dickson DW, Nicolas G, Campion D, Tschanz J, Schmidt H, Hakonarson H, Clarimon J, Munger R, Schmidt R, Farrer LA, Van Broeckhoven C, O'Donovan MC, DeStefano AL, Jones L, Haines JL, Deleuze JF, Owen MJ, Gudnason V, Mayeux R, Escott-Price V, Psaty BM, Ramirez A, Wang LS, Ruiz A, van Duijn CM, Holmans PA, Seshadri S, Williams J, Amouyel P, Schellenberg GD, Lambert JC, Pericak-Vance MA.

Nat Genet. 2019 Sep;51(9):1423-1424. doi: 10.1038/s41588-019-0495-7.

44.

Patient Blood Management is not about blood transfusion: it is about patients' outcomes.

Frietsch T, Shander A, Faraoni D, Hardy JF.

Blood Transfus. 2019 Sep;17(5):331-333. doi: 10.2450/2019.0126-19. Epub 2019 Jul 18. No abstract available.

45.

Risk of hospitalization for common neonatal morbidities in preterm and term infants: assessing the impact of one or more major congenital anomalies.

Hardy JR, Pimenta JM, Pokras S, Sehdev H, Laurent SS, Black L, Coyle M.

J Perinatol. 2019 Dec;39(12):1602-1610. doi: 10.1038/s41372-019-0460-4. Epub 2019 Aug 8.

PMID:
31395956
46.

Alginate/Chitosan Particle-Based Drug Delivery Systems for Pulmonary Applications.

Hill M, Twigg M, Sheridan EA, Hardy JG, Elborn JS, Taggart CC, Scott CJ, Migaud ME.

Pharmaceutics. 2019 Aug 2;11(8). pii: E379. doi: 10.3390/pharmaceutics11080379.

47.

Quality use of medicines: Oral corticosteroids in advanced cancer.

Pinkerton E, Good P, Kindl K, Richard R, Fischer A, Hardy JR.

Palliat Med. 2019 Aug 5:269216319866647. doi: 10.1177/0269216319866647. [Epub ahead of print] No abstract available.

PMID:
31378135
48.

Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia.

Bonham LW, Steele NZR, Karch CM, Broce I, Geier EG, Wen NL, Momeni P, Hardy J, Miller ZA, Gorno-Tempini ML, Hess CP, Lewis P, Miller BL, Seeley WW, Manzoni C, Desikan RS, Baranzini SE, Ferrari R, Yokoyama JS; International FTD-Genomics Consortium (IFGC).

Sci Rep. 2019 Jul 26;9(1):10854. doi: 10.1038/s41598-019-46415-1.

49.

Non-coding variability at the APOE locus contributes to the Alzheimer's risk.

Zhou X, Chen Y, Mok KY, Kwok TCY, Mok VCT, Guo Q, Ip FC, Chen Y, Mullapudi N; Alzheimer’s Disease Neuroimaging Initiative, Giusti-Rodríguez P, Sullivan PF, Hardy J, Fu AKY, Li Y, Ip NY.

Nat Commun. 2019 Jul 25;10(1):3310. doi: 10.1038/s41467-019-10945-z.

50.

Genes, pathways and risk prediction in Alzheimer's disease.

Hardy J, Escott-Price V.

Hum Mol Genet. 2019 Nov 21;28(R2):R235-R240. doi: 10.1093/hmg/ddz163.

PMID:
31332445

Supplemental Content

Support Center